MedTrace Logo

Efficacy and Safety of Hourly Titrated Misoprostol Versus Vaginal Dinoprostone and Misoprostol for Cervical Ripening and Labor Induction

NCT02902653 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 372

Last updated 2018-02-12

No results posted yet for this study

Summary

This study evaluates the efficacy and safety of the administration of oral misoprostol versus vaginal dinoprostone and vaginal misoprostol for cervical ripening and labor induction.

Conditions

  • Labor, Induced

Interventions

DRUG

Oral misoprostol

hourly titrated misoprostol

DRUG

Vaginal misoprostol

Administration of 25 microgs every 6 hours, maximum 150 microgr

DRUG

Vaginal dinoprostone

Vaginal delivery system of 10mg of dinoprostone

Sponsors & Collaborators

  • Oihane Lapuente Ocamica

    lead OTHER_GOV

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02902653 on ClinicalTrials.gov